chr15-79456234-C-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_015206.3(MINAR1):āc.87C>Gā(p.Asp29Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000774 in 1,614,020 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015206.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MINAR1 | NM_015206.3 | c.87C>G | p.Asp29Glu | missense_variant | 2/4 | ENST00000305428.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MINAR1 | ENST00000305428.8 | c.87C>G | p.Asp29Glu | missense_variant | 2/4 | 1 | NM_015206.3 | P1 | |
MINAR1 | ENST00000559272.1 | c.87C>G | p.Asp29Glu | missense_variant, NMD_transcript_variant | 1/4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000473 AC: 119AN: 251488Hom.: 0 AF XY: 0.000471 AC XY: 64AN XY: 135920
GnomAD4 exome AF: 0.000800 AC: 1170AN: 1461892Hom.: 2 Cov.: 32 AF XY: 0.000782 AC XY: 569AN XY: 727246
GnomAD4 genome AF: 0.000519 AC: 79AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.000498 AC XY: 37AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | The c.87C>G (p.D29E) alteration is located in exon 2 (coding exon 1) of the KIAA1024 gene. This alteration results from a C to G substitution at nucleotide position 87, causing the aspartic acid (D) at amino acid position 29 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at